Germany · Delayed Price · Currency is EUR MedMira Statistics
Total Valuation
MedMira has a market cap or net worth of EUR 32.38 million. The enterprise value is 42.68 million.
| Market Cap | 32.38M |
| Enterprise Value | 42.68M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 701.73M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +13.35% |
| Shares Change (QoQ) | +29.83% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | n/a |
| Float | 209.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 213.14 |
| PB Ratio | -2.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.93 |
| EV / Sales | 288.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -21.43 |
Financial Position
The company has a current ratio of 0.07
| Current Ratio | 0.07 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.31 |
| Interest Coverage | -3.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.02% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 19.58% |
| Revenue Per Employee | 2,922 |
| Profits Per Employee | -54,960 |
| Employee Count | 52 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 4.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.34% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.34% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 36.13 |
| Average Volume (20 Days) | 676 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedMira had revenue of EUR 151,922 and -2.86 million in losses. Loss per share was -0.00.
| Revenue | 151,922 |
| Gross Profit | -424,922 |
| Operating Income | -2.27M |
| Pretax Income | -2.86M |
| Net Income | -2.86M |
| EBITDA | -2.07M |
| EBIT | -2.27M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 9,418 in cash and 10.58 million in debt, giving a net cash position of -10.57 million.
| Cash & Cash Equivalents | 9,418 |
| Total Debt | 10.58M |
| Net Cash | -10.57M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -14.25M |
| Book Value Per Share | -0.02 |
| Working Capital | -12.90M |
Cash Flow
In the last 12 months, operating cash flow was -1.99 million and capital expenditures -4,717, giving a free cash flow of -1.99 million.
| Operating Cash Flow | -1.99M |
| Capital Expenditures | -4,717 |
| Free Cash Flow | -1.99M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -279.70% |
| Operating Margin | -1,492.57% |
| Pretax Margin | -1,881.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedMira does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.35% |
| Shareholder Yield | -13.35% |
| Earnings Yield | -8.83% |
| FCF Yield | -6.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |